rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael Kaseta

CFO and COO

Company insider

Files Form 4 as: CFO and COO, Liquidia; Director, Heron Therapeutics; Director, Alimera Sciences; Chief Financial Officer, Aralez Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
176
Buys
3
Sells
27
Bought
$132K
Sold
$34.5M
Companies
4
Companies where not an officer
2
First trade
30 Nov 2017
Last trade
12 Oct 2026
Last filed
13 Oct 2026

Companies traded

Where they are an officer
LQDA LiquidiaOfficer · Biotechnology · last 12 Oct 20263 buys · 27 sells
Aralez PharmaceuticalsOfficer · last 15 Mar 20180 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
HRTX Heron TherapeuticsDirector · Biotechnology · last 30 Jan 20260 buys · 0 sells
Alimera SciencesDirector · last 16 Sep 20240 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
50Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$539K18,938 at $28.48filing
9 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—5,828filing
9 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—7,049filing
9 Oct 2026filed 13 Oct 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—5,828 at $0.00filing
9 Oct 2026filed 13 Oct 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—7,049 at $0.00filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$104K1,453 at $71.39filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$1.4M18,977 at $71.52filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$104K1,453 at $71.39filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$1.4M18,977 at $71.52filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—5,829filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—7,050filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—5,829 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—7,050 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—5,829 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—7,050 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—5,829filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—7,050filing
15 Apr 2026filed 16 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$363K9,044 at $40.14filing
15 Apr 2026filed 16 Apr 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—86,971 at $0.00filing
15 Apr 2026filed 16 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$243K86,971 at $2.79filing

Sectors

Health Care30

Buys in green, sells in red, by the company’s sector.

Related people

Roger JeffsChief Executive Officer · Chief Executive Officer at Liquidia, filing Form 4 there in the last year
Jason AdairChief Business Officer · Chief Business Officer at Liquidia, filing Form 4 there in the last year
Scott MoomawChief Commercial Officer · Chief Commercial Officer at Liquidia, filing Form 4 there in the last year
Russell SchundlerGeneral Counsel · General Counsel at Liquidia, filing Form 4 there in the last year
Rajeev SaggarChief Medical Officer · Chief Medical Officer at Liquidia, filing Form 4 there in the last year
Dana BoyleChief Accounting Officer · Also traded LQDA in the last 90 days
Sanjeev KhindriChief Development Officer · Also traded LQDA in the last 90 days
Sarah KreppChief Human Resource Officer · Also traded LQDA in the last 90 days